Rising Star: Mayer Brown's Andrew Calica
Mayer Brown LLP partner Andrew Calica has secured a string of game-changing victories in litigation implicating branded-drug maker UCB Inc. over alleged neurological disorders caused by its heartburn drug Reglan, landing...To view the full article, register now.
Already a subscriber? Click here to view full article